tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Takeda Pharmaceutical Co Ltd

TAK
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
18.450USD
-0.260-1.39%
์ข…๊ฐ€ย 09-04 16:00๏ผˆET๏ผ‰
58.33B์‹œ๊ฐ€์ด์•ก
48.06P/E TTM

Takeda Pharmaceutical Co Ltd

18.450
-0.260-1.39%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

TAK ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Takeda Pharmaceutical Co Ltd์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Jul 30, 2026
EPS / ์˜ˆ์ƒ
0.22/0.89
์ˆ˜์ต / ์˜ˆ์ƒ
7.65B/7.67B
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2026 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
28.54B
-9.09%
EPS(YoY)
-0.30
-233.73%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/09/07
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-20.05%0.22
-237.52%-0.74
338.66%0.21
-112.49%-0.03
46.07%0.28
---0.22
-80.00%0.05
297.08%0.20
-5.27%0.19
----
-18.27%0.24
---0.10
--0.20
--0.08
--0.29
--107.62
----
----
----
----
----
์ˆ˜์ต
3.31%7.65B
-3.95%6.93B
4.98%7.78B
-6.66%7.22B
-8.09%7.40B
3.95%7.22B
-2.29%7.41B
11.52%7.74B
6.09%8.05B
-2.28%6.95B
-10.96%7.59B
1.22%6.94B
4.83%7.59B
5.76%7.11B
8.71%8.52B
-7.89%6.85B
-16.34%7.24B
-5.25%6.72B
-1.10%7.84B
-1.36%7.44B
----
์ˆœ์ด์ต
-14.61%709.65M
-230.18%-2.33B
339.11%676.99M
-112.65%-76.58M
30.86%831.06M
-3444.49%-706.98M
-78.65%154.17M
289.56%605.45M
-0.94%635.07M
-108.62%-19.95M
-22.02%722.03M
-175.67%-319.39M
-18.02%641.10M
364.78%231.41M
84.25%925.98M
4.29%422.11M
-37.69%782.05M
-104.82%-87.40M
-42.57%502.57M
948.83%404.76M
----
์ˆœ์ด์ต๋ฅ 
-17.33%9.28%
-243.91%-33.66%
317.84%8.70%
-113.46%-1.05%
42.35%11.23%
---9.79%
-78.11%2.08%
270.30%7.83%
-6.59%7.89%
----
-12.41%9.52%
---4.60%
--8.45%
--3.26%
--10.87%
--8.44%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
8.33%58.01%
8.48%53.50%
5.94%54.91%
-1.15%54.04%
-5.20%53.55%
--49.32%
-3.67%51.83%
0.24%54.66%
-2.65%56.49%
----
-5.59%53.81%
--54.53%
--58.03%
--53.67%
--57.00%
--55.84%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-1.98%31.54%
-16.04%31.47%
-1.69%31.50%
-7.38%32.10%
-4.74%32.17%
--37.49%
-2.30%32.04%
10.16%34.66%
5.25%33.78%
----
3.31%32.79%
--31.46%
--32.09%
--31.40%
--31.74%
--32.47%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
3.31%7.65B
-3.95%6.93B
4.98%7.78B
-6.66%7.22B
-8.09%7.40B
3.95%7.22B
-2.29%7.41B
11.52%7.74B
6.09%8.05B
-2.28%6.95B
-10.96%7.59B
1.22%6.94B
4.83%7.59B
5.76%7.11B
8.71%8.52B
-7.89%6.85B
-16.34%7.24B
-5.25%6.72B
-1.10%7.84B
-1.36%7.44B
----
์˜์—… ์ด์ต
3.73%1.30B
-349.72%-2.31B
160.13%1.14B
-25.03%926.15M
-1.61%1.25B
-288.17%-513.55M
-50.66%438.38M
208.55%1.24B
1.36%1.27B
-63.21%272.92M
-29.39%888.55M
-43.93%400.37M
11.82%1.25B
206.61%741.82M
0.98%1.26B
-35.34%714.01M
-53.65%1.12B
-85.40%241.94M
-19.78%1.25B
28.32%1.10B
----
์ˆœ์ด์ต
-14.61%709.65M
-230.18%-2.33B
339.11%676.99M
-112.65%-76.58M
30.86%831.06M
-3444.49%-706.98M
-78.65%154.17M
289.56%605.45M
-0.94%635.07M
-108.62%-19.95M
-22.02%722.03M
-175.67%-319.39M
-18.02%641.10M
364.78%231.41M
84.25%925.98M
4.29%422.11M
-37.69%782.05M
-104.82%-87.40M
-42.57%502.57M
948.83%404.76M
----
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
17.49%19.75B
13.31%19.58B
14.04%20.36B
-5.66%18.95B
-18.87%16.81B
--17.28B
7.61%17.85B
22.70%20.09B
16.87%20.72B
----
-17.79%16.59B
-12.78%16.37B
-6.63%17.73B
-10.69%17.82B
-6.39%20.18B
-13.22%18.77B
-15.89%18.99B
-20.10%19.96B
-13.05%21.56B
-12.47%21.63B
-3.42%22.57B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
19.43%17.33B
4.44%17.94B
25.40%17.05B
-11.59%13.88B
-11.71%14.51B
--17.18B
-12.77%13.60B
-0.27%15.70B
-8.39%16.44B
----
-10.35%15.59B
-3.71%15.74B
11.18%17.94B
11.73%18.45B
10.47%17.39B
-3.23%16.35B
3.72%16.14B
1.13%16.51B
-7.97%15.74B
3.38%16.90B
-18.91%15.56B
์ด ์ž์‚ฐ
4.83%98.20B
0.63%98.27B
2.80%100.65B
-2.05%93.89B
-13.42%93.68B
--97.65B
0.79%97.91B
-3.07%95.86B
1.99%108.20B
----
-7.46%97.14B
-0.85%98.90B
1.28%106.09B
2.31%103.74B
-4.98%104.97B
-9.82%99.74B
-9.22%104.75B
-14.71%101.40B
-5.10%110.47B
-6.80%110.60B
-3.15%115.38B
๋ถ€์ฑ„ ์ด๊ณ„
6.41%50.81B
2.15%51.19B
1.80%50.72B
-5.39%47.62B
-15.03%47.75B
--50.12B
-2.48%49.82B
-2.98%50.33B
-0.44%56.20B
----
-10.31%51.09B
-3.65%51.87B
-2.17%56.45B
-2.00%56.51B
-11.12%56.96B
-15.50%53.84B
-14.68%57.70B
-19.03%57.67B
-11.55%64.09B
-13.97%63.72B
-9.63%67.63B
์ž๋ณธ ์ด๊ณ„
3.18%47.39B
-0.97%47.07B
3.85%49.93B
1.64%46.27B
-11.68%45.93B
--47.54B
4.42%48.08B
-3.18%45.53B
4.76%52.00B
----
-4.08%46.05B
2.45%47.02B
5.51%49.64B
8.00%47.23B
3.51%48.01B
-2.11%45.90B
-1.48%47.05B
-8.25%43.73B
5.52%46.38B
5.11%46.89B
7.79%47.75B
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-47.16%702.44M
-82.61%223.19M
-0.51%2.24B
32.99%2.22B
28.76%1.33B
-24.40%1.28B
181.06%2.26B
48.73%1.67B
98.33%1.03B
-15.93%1.70B
-70.03%802.33M
-13.95%1.12B
13.71%520.55M
-25.50%2.02B
-2.39%2.68B
-27.19%1.31B
-65.04%457.78M
-22.07%2.71B
59.62%2.74B
-17.98%1.79B
----
์ˆœํˆฌ์ž
-147.64%-549.83M
-172.49%-367.55M
-100.44%-1.50B
36.80%-312.31M
78.75%-222.03M
66.81%-134.88M
-45.68%-748.90M
-22.68%-494.19M
45.34%-1.04B
87.53%-406.34M
-41.65%-514.06M
-116.58%-402.84M
-170.99%-1.91B
-1552.10%-3.26B
39.66%-362.92M
35.81%-186.00M
-9.84%-705.35M
-107.30%-197.28M
-188.19%-601.46M
-209.97%-289.75M
----
์ˆœ์žฌ๋ฌดํ™œ๋™
22.09%-1.03B
86.77%-241.96M
73.56%-1.06B
128.00%153.28M
-159.92%-1.33B
-657.65%-1.83B
-755.54%-4.02B
25.69%-547.35M
912.70%2.21B
-311.04%-241.44M
84.93%-469.79M
-391.32%-736.53M
81.05%-272.25M
106.74%114.40M
-163.89%-3.12B
92.19%-149.91M
59.36%-1.44B
46.88%-1.70B
52.67%-1.18B
3.53%-1.92B
----

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Takeda Pharmaceutical Co Ltd์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 28.54B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.40B์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 19.58B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.31์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ด์ž์‚ฐ์€ 98.27B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.63์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ด๋ถ€์ฑ„๋Š” 51.19B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.15์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ด์ž๋ณธ์€ 47.07B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.97์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ 4.21B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.79์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ˆœํˆฌ์ž๋Š” -2.34B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.04์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -2.38B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 45.64์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.30์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -233.73์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -965.41M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -230.52์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -3.38์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -243.04์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 54.09์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.03์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 31.47์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.69์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -1.02์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -238.77์ž…๋‹ˆ๋‹ค.

Takeda Pharmaceutical Co Ltd์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Takeda Pharmaceutical Co Ltd์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 4.21B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.79์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ